Evidence map›Paper›PMID 37037993›Full record

Observational studyNeurocritical care2023

White Blood Cell Count Predicts Mortality in Patients with Spontaneous Intracerebral Hemorrhage.

Jialing He, Yu Zhang, Xin Cheng, Tiangui Li, Yangchun Xiao, Liyuan Peng, Yuning Feng, Jinxiao He, Pengfei Hao, Haidong Deng and 7 more

Abstract readObservational Study
PubMed Publisher
In one paragraph

Observational study in Neurocritical care, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

17 authors.

Jialing He *Department of Neurosurgery, West China Hospital, Sichuan University, No. 37, Guo Xue Xiang, Chengdu, 610041, Sichuan, China.
Yu Zhang *Evidence-Based Medicine Center, Department of Critical Care Medicine, Department of Anesthesia, Department of Neurosurgery, Affiliated Hospital of Chengdu University, Chengdu, Sichuan, China.
Xin ChengDepartment of Neurosurgery, West China Hospital, Sichuan University, No. 37, Guo Xue Xiang, Chengdu, 610041, Sichuan, China.
Tiangui LiDepartment of Neurosurgery, The First of People's Hospital of Longquanyi District, Chengdu, Sichuan, China.
Yangchun XiaoEvidence-Based Medicine Center, Department of Critical Care Medicine, Department of Anesthesia, Department of Neurosurgery, Affiliated Hospital of Chengdu University, Chengdu, Sichuan, China.
Liyuan PengEvidence-Based Medicine Center, Department of Critical Care Medicine, Department of Anesthesia, Department of Neurosurgery, Affiliated Hospital of Chengdu University, Chengdu, Sichuan, China.
Yuning FengEvidence-Based Medicine Center, Department of Critical Care Medicine, Department of Anesthesia, Department of Neurosurgery, Affiliated Hospital of Chengdu University, Chengdu, Sichuan, China.
Jinxiao HeNanchong Institute for Food and Drug Control, Nanchong, Sichuan, China.
Pengfei HaoDepartment of Neurosurgery, Shanxi Provincial People's Hospital, Taiyuan, Shanxi, China.
Haidong DengEvidence-Based Medicine Center, Department of Critical Care Medicine, Department of Anesthesia, Department of Neurosurgery, Affiliated Hospital of Chengdu University, Chengdu, Sichuan, China.
Peng WangEvidence-Based Medicine Center, Department of Critical Care Medicine, Department of Anesthesia, Department of Neurosurgery, Affiliated Hospital of Chengdu University, Chengdu, Sichuan, China.
Weelic ChongDepartment of Medical Oncology, Thomas Jefferson University, Philadelphia, PA, USA.
Yang HaiSidney Kimmel Medical College, Thomas Jefferson University, Philadelphia, PA, USA.
Lvlin ChenEvidence-Based Medicine Center, Department of Critical Care Medicine, Department of Anesthesia, Department of Neurosurgery, Affiliated Hospital of Chengdu University, Chengdu, Sichuan, China.
Chao YouDepartment of Neurosurgery, West China Hospital, Sichuan University, No. 37, Guo Xue Xiang, Chengdu, 610041, Sichuan, China.
Lu JiaDepartment of Neurosurgery, Shanxi Provincial People's Hospital, Taiyuan, Shanxi, China.
Fang FangDepartment of Neurosurgery, West China Hospital, Sichuan University, No. 37, Guo Xue Xiang, Chengdu, 610041, Sichuan, China. fangfang01@scu.edu.cn.ORCID http://orcid.org/0000-0003-2961-1254

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundThe association between white blood cell (WBC) counts and mortality in patients with intracerebral hemorrhage (ICH) has not been established. The aim of this study is to determine whether higher WBC is associated with mortality at 90 days.

methodsA retrospective observational study was conducted at two medical hospitals in China. Baseline WBC count on admission served as the primary predictor variable. Longitudinal WBC counts within the first week after admission were collected to assess the effects of WBC trajectory and the median and maximum WBC counts on outcomes following ICH. Associations of WBC count with outcomes were evaluated in multivariable regression analyses.

resultsWe identified 3613 patients with ICH who met the inclusion criteria. After adjusting primary confounding variables, patients with increased WBC count had a significantly higher risk of 90-day mortality (p < 0.001 for trend). In the receiver operating characteristic analyses, the capacity for all-cause mortality prediction by WBC count on admission (area under the ROC curve (AUC) = 0.65) was superior to other important inflammatory markers, including neutrophil (AUC = 0.64) , lymphocyte (AUC = 0.57), albumin (AUC = 0.57), and platelet count (AUC = 0.53), p < 0.001 for WBC vs. neutrophil, and the median WBC count (AUC = 0.66) within the first week after admission was a better marker than admission WBC count (p = 0.02).

conclusionsIn patients with ICH, WBC count on admission was associated with all-cause mortality at 90 days. Additionally, the median and maximum WBC counts within the first week after admission showed better predictive ability for the 90-day mortality compared with the WBC count on admission.

Indexed as

Cerebral HemorrhageLymphocytesHumansLeukocyte CountNeutrophilsPrognosisRetrospective StudiesROC CurveIntracerebral hemorrhageMortalityPrognosesWhite blood cell

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.